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Abstract
Epidemiological data suggest that plant-derived phenolics beneficial effects include an inhibition of LDL oxidation. After
applying a screening method based on 2,4-dinitrophenyl hydrazine- protein carbonyl reaction to 21 different plant-derived
phenolic acids, we selected the most antioxidant ones. Their effect was assessed in 5 different oxidation systems, as well as
in other model proteins. Mass-spectrometry was then used, evidencing a heterogeneous effect on the accumulation of the
structurally characterized protein carbonyl glutamic and aminoadipic semialdehydes as well as for malondialdehyde-lysine
in LDL apoprotein. After TOF based lipidomics, we identified the most abundant differential lipids in Cu++-incubated LDL as
1-palmitoyllysophosphatidylcholine and 1-stearoyl-sn-glycero-3-phosphocholine. Most of selected phenolic compounds
prevented the accumulation of those phospholipids and the cellular impairment induced by oxidized LDL. Finally, to
validate these effects in vivo, we evaluated the effect of the intake of a phenolic-enriched extract in plasma protein and lipid
modifications in a well-established model of atherosclerosis (diet-induced hypercholesterolemia in hamsters). This showed
that a dietary supplement with a phenolic-enriched extract diminished plasma protein oxidative and lipid damage. Globally,
these data show structural basis of antioxidant properties of plant-derived phenolic acids in protein oxidation that may be
relevant for the health-promoting effects of its dietary intake.
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Introduction
The oxidative stress hypothesis of atherosclerosis is based on the
fact that free radical-derived damage participates in atherogenesis
pathophysiology by means of LDL modification, among other
mechanisms [1–3]. Supporting this hypothesis, LDL modified by
oxidation (oxLDL) has been detected in atherosclerotic lesions [4–
6] and oxLDL exhibits various proatherogenic activities in vitro
[3,7].
It is important to emphasize that oxLDL represents a
heterogeneous population of modified forms of LDL that differ
greatly in their chemical composition and biological properties.
The conversion of native LDL into highly modified LDL via
oxidative processes can occur by two major mechanisms: In the
first case, the events start with the complete loss of LDL’s
endogenous antioxidants (i.e., a-tocopherol, ubiquinol-10), fol-
lowed by the conversion of a majority of the polyunsaturated fatty
acids (PUFA) into their corresponding hydroperoxides. Then,
these primary lipid oxidation products are fragmented into
secondary lipid oxidation products, such as malonyldialdehyde
or 4-hydroxynonenal, which can react with the Ng-amino group
of lysine residues from LDL apoprotein (Apo B-100). Conse-
quently, the particle’s electrophoretic mobility increases and the
lipoprotein becomes ‘‘high uptake’’ [8]. Additionally, in the
subendothelial space, oxLDL may exert a ‘‘Trojan horse effect’’,
e.g. allowing the diffusion of those lipid mediators modifying
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endothelial and vascular smooth muscle cells. The second case is
characterized by the immediate and preferential oxidation of
amino acid residues from Apo B-100 in the absence of substantial
consumption of lipid soluble antioxidants and/or occurrence of
lipid peroxidation [9]. Nevertheless, apoprotein oxidative modifi-
cations have been not studied as extensively as lipid-phase ones.
The beneficial effects of Mediterranean diet concerning
cardiovascular diseases are well known. Most of them are
associated with olive oil and wine consumption [10,11], nutrients
with a high content of phenolic acids. With regard to the influence
of diet on atherosclerosis, the ingestion of fruits and vegetables
(phenolic-rich vegetal sources) is related to a lesser development of
atheroma plaque [12,13]. This effect is mainly attributed with
their protective effects against LDL oxidation [14–17]. Despite a
great deal of research having been devoted to the prevention of
lipid peroxidation in LDL by antioxidants, including phenolic
acids [18–21], few studies have reported the prevention of protein
oxidation in LDL by exogenous antioxidants. Apo B-100
modifications, e.g., the binding of lipid peroxidation products or
direct oxidation of amino acid side-chain residues, are thought to
finally result in the formation of new epitopes that are specifically
recognized by scavenger receptors [22–25], but the potential
preventive effect of nutritional compounds on apoprotein oxida-
tive modifications have not been studied so extensively.
To fill those gaps, the antioxidant effect of 21 different vegetal-
derived phenolic compounds (mainly founded in olive oil and
grape-derived products) in the oxidation of apolipoprotein of
human LDL was assessed in this study. For that purpose, the
quantification of carbonyl groups (detected by Western-Blot) was
carried out in LDL-model systems. The antioxidant behaviour of
the more active phenols was then further characterized by
measuring the protection of the lipidome changes induced by
Cu++, the accumulation of specific oxidation and lipid peroxida-
tion markers in LDL apoproteins. The preventive role on the loss
of cell viability induced by Cu++-treated LDL was tested using
these phenolic compounds. Finally, in order to test whether those
or related phenolic compounds would have similar effects in vivo in
an atherosclerosis model, carbonyl content of plasma proteins and
lipid oxidation markers were analysed in hypercholesterolemic
hamsters fed with a phenolic- enriched diet.
Methods
Reference Compounds
a-Tocopherol was purchased from Sigma-Aldrich Chemical Co
(St. Louis, MA, USA). Phenolic standards from the following
sources were used without further purification: 2-(3,4-dihydrox-
yphenyl)-4,5-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-
6-methyl-oxan-2-yl)oxymethyl]oxan-2-yl]oxy-chromen-7-one (ru-
tin), 49,5,7-tihydroxyflavone (apigenin), apigenin 7-O-glucoside,
39,49,5,7-tetrahydroxyflavone (luteolin), luteolin 7-O-glucoside,
trans-4-hydroxycinnamic acid (p-coumaric acid), 2-(3,4-dihydrox-
yphenyl) ethyl alcohol (OH-tyrosol) (3,4-DHPEA), 2-(4-hydroxy-
phenyl) ethyl alcohol (tyrosol) (p-HPEA), oleuropein, verbascoside
and vanillin from Extrasynthese (Genay, France); 3,4-dihydrox-
ycinnamic acid (caffeic acid), ferulic acid, and 3,4,5-trihydrox-
ybenzoic acid (gallic acid) from Fluka Co. (Buchs, Switzerland);
Pinoresinol from Arbonova Sales (Turku, Finland). Phenolic
enriched grape seed extract was obtained as previously described
[26].
Isolation of Phenolic Compounds by Semipreparative
HPLC
Secoiridoid derivatives 4-(acetoxyethyl)-1,2-dihydroxybenzene
(3,4-DHPEA-AC), 4-hexenoic acid, 4-formyl-3-(2-oxoethyl)-2-(3,4
dihydroxyphenyl) ethyl ester (3,4-DHPEA-EDA), methylated form
of the oleuropein aglycone (ME 3,4-DHPEA-EA) and 4-hexenoic
acid, 4-formyl-3-(2-oxoethyl) 2-(4-hydroxyphenyl) ethyl ester (p-
HPEA-EDA) were isolated from virgin olive oil phenolic extract by
semi-preparative HPLC method according to the method of
Artajo et al. [27]. Stock solutions of commercial standards and
phenolic compounds isolated from virgin olive oil were dissolved in
methanol/H2O (80:20 v/v) and stored at 240uC before the
evaluation of their antioxidant activity. The chemical structures of
the phenols included in the study are shown in Figure S1.
Hypercholesterolemic hamsters and human plasma
Twelve male Gold Syrian hamster weighing 127.5566.75 g
were randomly assigned to two groups (n = 6 for each group) with
approximately equal mean group body weights. They were caged
and maintained in a 12:12 (light:dark) cycle at 2262uC and
50610% relative humidity with free access to both food and
water. Food intake and body weight were controlled every week.
The control group ate an atherogenic diet [28] in which the
cholesterol content had been set at 5% and which was
supplemented with 15% of lard, and the experimental group ate
this atherogenic diet supplemented with a 0.2% of phenolic-
enriched vegetal extract (Table 1). The diets were maintained
during 12 weeks and the animals were deprived of food for 15 h.
Hamsters were anesthetized and then sacrificed by heart puncture
and plasma and serum were collected and stored at 220uC until
analysis. For metabolomic analyses, the method of Wikoff et al was
used [29]. The plasma triglycerides, cholesterol, HDL, LDL, and
alkaline phosphatase content were quantified by enzymatic
Table 1. Control and supplemented diet composition.
Component Control (g) Supplemented (g)
Casein 200 200
L-Cysteine 3 3
Corn starch 362 362
Sugar 140 140
Corn oil 0 0
Cellulose 50 48
Minerals 35 35
Lard 150 150
Vitamins 10 10
Cholesterol 50 50
Polyphenol extract 0 2
Total weight 1000 1000
Energy (Kcal/g diet) 4.62 4.62
Carbohydrates (g/Kg) 502 502
% Energy 43.5 43.5
Proteins (g/Kg) 203 203
% Energy 17.6 17.6
Lipids 200 200
% Energy 39 39
The control diet is an atherogenic diet.
doi:10.1371/journal.pone.0043308.t001
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colorimetric reactions using commercial kits (Spinreact, Girona,
Spain).
Human plasma was obtained from 6 different, healthy male
donors after an overnight fast (mean age: 2563) by standard
venepuncture and centrifugation using EDTA coated Vacutainer
tubes. Both plasma obtention and animal experiments were
supervised and approved by the Experimental and Ethics
Committee of the University of Lleida.
Protein oxidation screening method: Protein oxidation
and Western blot analysis
Aliquots of phenolic acid compounds dissolved in methanol
were transferred to Eppendorf tubes and desiccated under a
nitrogen current at room temperature. The dried phenols were
redissolved to a final concentration of 5 mM with PBS (except
when indicated) containing dissolved protein. Then, protein
(700 mg/ml) was oxidized by exposure to different prooxidants.
We used i) CuSO4 (5 mmol/l free Cu
++); ii) Hemin:H2O2
(30 mmol/l: 5 mmol/l); iii) H2O2 (5 mmol/l); iv) Ascorbate:Fe
3+
(1.5 mmol/l: 8 mmol/l); v) ultraviolet radiation (l 254 nm) and v)
myeloperoxidase (MPO) (0.77 U/mL and H2O2 100 mmol/l) in
phosphate buffered media at 37uC for 3 hours, according
published procedures [30]. All samples were used immediately
or stored at 280uC for further analysis.
To assess the extent of protein oxidation, 2,4-dinitrophenylhy-
drazine (DNP)-reactive carbonyls were measured by Western Blot
as previously described [31] (See Methods S1 to further
information).
Measurement of glutamic (GSA) and aminoadipic (AASA)
semialdehydes and malondialdehyde lysine (MDAL)
The concentration of chemically characterized markers of
protein oxidative modification GSA, AASA, and MDAL, in LDL
apoproteins was evaluated by gas chromatography/mass spec-
trometry (GC/MS) as previously described [31] (See Methods S1
to further information).
Lipidome analyses
Lipid composition was assessed by both fatty acid analysis (see
Methods S1 to further information) and time of flight mass
spectrometry (TOF)-based lipid molecular species analyses. In
both cases the total lipids from LDL were extracted with
chloroform:methanol (2:1, v/v) in the presence of 0.01% butylated
hydroxytoluene as previously described [31].
For TOF-based lipid molecular species analyses, lipid extracts
(from LDL) or methanolic extracts (from hamster’s plasma) were
submitted to mass-spectrometry using a LC ESI-QTOF MS/MS
6520 (Agilent Technologies, Barcelona, Spain), coupled to a
capillary LC module using an untargeted approach as described
[29] (see Methods S1 to further information). In order to offer a
relative quantification of 1-palmitoyl-2-(5-oxovaleryl)-sn-glycero-3-
phosphocholine (POVPC) and 1-palmitoyl-2-glutaryl-sn-glycero-3-
phosphocholine (PGPC), bioactive lipids present in oxLDL mass
profiles [32] were integrated for an m/z of 594.3 for POVPC and
610.2 for PGPC with a D of 0.01 Da.
FRAP assay
The ferric reducing antioxidant power of the samples was
estimated according to the procedure previously described [33,34].
Briefly, FRAP reagent, was mixed with distilled water and either of
sample or appropriate reagent blank. The readings at 30 min were
selected for calculation of FRAP values. Reduction power activities
were as mmol of Trolox equivalents, per gram of dry matter.
Cell viability
Both HMEC (kindly providen by Anne Negre-Salvayre,
INSERM, Toulouse [35] and HepG2 viability were measured
with the MTT-based Cell Toxicity Colorimetric Assay Kit (Sigma-
Aldrich, St.Louis, MA, USA) according to the manufacturer’s
instructions after oxLDL tert-butylhydroperoxide (t-BOOH) as
described [36,37]. The results were expressed as the percentage of
viability versus cells exposed to non-oxidized LDL or untreated
with t-BOOH. Further details are described in the Methods S1
section.
Statistical analyses
All statistics were analysed using the SPSS software (SPSS Inc.,
Chicago, IL, USA). Differences between the groups were analysed
by the Student’s T tests or ANOVA (with post-hoc analyses for
detecting differences between specific pairs), after assessment of
normal distribution of variables by the Kolmogorov-Smirnoff test.
Correlations between variables were evaluated by the Pearson
statistic and plotted with the Metaboanalyst software [38] The
0.05 level was selected as the point of minimal statistical
significance in every comparison.
Results
Effect of individual phenolic compounds on LDL
oxidation. LDL oxidation by different methods induces
accumulation of carbonyl in LDL apoproteins: differential
inhibitory potential of phenolic compounds
The antioxidant capacity was quantified after Western Blot of
DNP reactive carbonyls in LDL apoproteins (Figure 1A) being the
value corresponding to oxLDL considered 0% of antioxidant
capacity. The anti-DNP immunoreactivities which are lower than
that found in oxLDL were interpreted as anti-oxidant activity and
that which are higher as prooxidant activities. The different
phenols were tested at three concentrations (5, 50 and 100 mM)
(Figure 1B), using a-tocopherol as a reference. Apoprotein
oxidation was significantly inhibited by the majority of the phenols
tested. The OH-tyrosol showed the maximal efficiency even at
5 mM, higher than the efficiency of a-tocopherol. Luteolin
(flavonoid), pinoresinol (lignan), gallic and caffeic acids showed a
good efficiency which was concentration-dependent. These
phenols reduced the Cu++ inducted oxidation by between 60
and 80%. The secoiridoid derivatives (3,4-DHPEA-EDA and p-
HPEA-EDA) showed a slight activity, similarly to a-tocopherol.
Other phenols, such as verbascoside, vanillin, 3,4-DHPEA-AC
and the methylated form of the oleuropein aglycone (ME 3,4-
DHPEA-EA) showed lower antioxidant activity with oxidation
inhibition values below 20%. The prooxidant effect shown by
some phenols, such as oleuropein, tyrosol and apigenin in its
aglycone and glucosidic forms should also be noted.
As Figure 1B shows, different phenolic compounds exhibit
differential effects in a dose dependent fashion, in the apoprotein
moiety of human LDL. According to this first screening, the more
active phenols selected were: OH-tyrosol (OH-tyrosol), 3,4-
DHPEA-EDA (3,4-DHPEA) as secoiridoid derivative; pinoresinol
(Pin) as a lignane; luteolin (Lut) as a flavonoid; and gallic (Gallic)
acids as a phenolic acid.
In order to extend those findings from Cu++ to other oxidation
systems, we measured the effects of phenolics in different systems
ranging from ultraviolet radiation to enzymatic paradigm
(Figure 1C, D, E, F and G). Of those, only UVA, Fe+3-Asc and
H2O2 increased carbonyl content more than 50% in LDL
(Figure 1D, E and F). In those systems, all phenols analysed had
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a strong antioxidant action, with the exception of Fe+3-Asc, where
only luteolin (and 3,4-DHPEA and pinorresinol to a minor extent)
had a significant effect. Of note, pathogenically relevant systems
such as MPO+H2O2 do not offer a significant increase in carbonyl
staining (Figure 1G). Most importantly, all selected phenolic
compounds are able to significantly inhibit the accrual of carbonyl
modification after MPO+H2O2 incubation, being pinoresinol the
most active.
In order to extent those results to other proteic systems, BSA
and human plasma were oxidized using Hemin-H2O2, UVA and
Fe3+-Asc. These results (Figure S2) do not allow to distinguish any
individual phenol as a general antioxidant, i.e. its effect being
independent of the protein and oxidation-system used. Generally,
BSA is less oxidizable than LDL in same conditions, and only
pinoresinol and luteolin diminish significantly protein oxidation in
specific systems (Figure S2B and S2C). In contrast, human plasma
is more oxidizable than BSA (under UVA and Fe+3-Asc). Under
Fe3+-Asc, again pinoresinol and luteolin stand out as significant
inhibitors of protein oxidation in plasma (Figure S2E and S2F). Of
note, several polyphenols (notably gallic acid) exhibited prooxidant
actions under these conditions (Figure S2B and S2D).
Cu++ incubation induces accumulation of metal-
catalyzed oxidation (MCO), lipoxidation markers in LDL
apoproteins and changes in LDL lipidome: differential
inhibitory potential of phenolic acid compounds
Taking into account that DNP reactive carbonyls could arise
from either lipid peroxidative damage or the direct modification of
aminoacid residues by MCO [39] specific probes for each of those
oxidative modifications were measured by using GC/MS. The
results show that Cu++ incubation led to significant increases in the
MCO markers GSA, AASA and an even greater increase in the
lipoxidation marker MDAL (Figure 2A, B and C). OH-tyrosol and
the lignane were the most effective compounds for inhibiting GSA
accumulation. Luteolin also prevented its accumulation in Cu++-
treated LDL. Neither gallic acid, nor 3,4-DHPEA-EDA were
effective (Figure 2A). A similar pattern was observed for AASA
accumulation, but in this case, gallic acid was significant inhibitors
of its formation (Figure 2B). Finally, OH-tyrosol and pinoresinol
were potent antioxidants in considering MDAL accumulation,
while 3,4-DHPEA-EDA, and specially luteolin (with no significant
effect), were among the lowest in this sense (Figure 2C). To
reinforce the importance of the lipid composition in relation with
the lipoxidative modifications of proteins, a significant correlation
was observed (r2 = 0.91; p,0.0001) between PI and MDAL
formation (Figure 2D).
Carbonyl modification of apoproteins can arise from lipid
peroxidation. In such a case, the LDL fatty acid composition
exhibits PUFA consumption. To test this, the fatty acid
composition of LDL was analysed after Cu++-induced oxidation,
demonstrating significant losses in PI and PUFA content (Table 2).
For this reason we examined the potential for prevention of this
phenomenon. OH-tyrosol, and the lignane were among the most
potent compounds, almost preventing the effect of Cu++. Gallic
acid was less potent, and luteolin and 3,4-DHPEA-EDA had
almost no effect on the oxidative modification of LDL
After TOF-based analyses of oxLDL, palmitoyllysophosphati-
dylcholine (PLPC), 1-stearoyl-sn-glycero-3-phosphocholine
(SGPC) and 1-oleoylglycerophosphocholine (OGPC) comprised
more than 90% of the differentially present lipids in Cu++-treated
LDL (Figure 2E). Similarly to the fatty acid analyses, luteolin and
gallic acid exhibit the lowest capacity for preventing the build-up
of PLPC, while the other compounds prevented the accumulation
of this compound almost completely. Luteolin was the only
compound unable to inhibit the formation of SGPC (Figure 2F
and 2G).
Taking into account that 1-palmitoyl-2-(5-oxovaleryl)-sn-gly-
cero-3-phosphocholine (POVPC) and 1-palmitoyl-2-glutaryl-sn-
glycero-3-phosphocholine (PGPC) have been identified as biolog-
ical effectors of oxLDL [32], the presence of those compounds was
ensured. As expected, their level increased in Cu++-treated samples
(12 and 4-fold over untreated samples, respectively). Luteolin and
gallic acid prevented the accumulation PLPC to a lower extent
when compared with the other compounds (Figure 2F).
Biological relevance of plant-derived phenolics
antioxidant effects: Loss of cell viability induced by Cu++-
treated LDL and in vivo evidences of protein and lipid
antioxidant activity
To further reinforce the biological relevance of the antioxidant
potential of those compounds and the methodology described here
for its identification, we examined the cytotoxic potential of Cu++
incubated LDL in an endothelial cell culture model. For this
purpose, the endothelial cell line HMEC-1 was treated with Cu++-
treated LDL and 18 h later, the viability of the cultures was
assessed with the MTT assay. The results demonstrate that oxLDL
led to a loss of 60% of viability and OH-tyrosol prevented partially
those effects (Figure 3A), inducing only a 10% of viability loss.
Unexpectedly, luteolin, a compound with a low antioxidant
potential, based on lipidome changes, showed a significant
preventive effect on the oxLDL induced loss of viability.
To ascertain whether this was due to a specific cellular effect
(e.g. by modulation of antioxidant cellular responses in endothelial
cells), we examined the potential influence of those compounds in
tert-BOOH-mediated cell death in a HepG2 cell line, an unrelated
cell line. Those analyses demonstrate that luteolin, OH-tyrosol and
3,4-DHPEA-EDA were the only compounds able to prevent
significantly the loss of viability secondary to treatment with tert-
BOOH (Figure 3B).
The correlation of cell viability with antioxidant capacity
reinforced the pathogenic importance of LDL apoprotein oxida-
tive modification, as that GSA amount showed the most significant
correlation with the loss of viability induced by oxLDL (Figure 3C).
Figure 1. Plant-derived phenolic acids inhibit protein oxidation in isolated human LDL to varying degrees. A. Representative Western
Blot of the screening phase for LDL apoprotein protection in oxLDL. Data are presented for 3,4-DHPEA-AC, apigenin, rutin, p-cumaric acid and
apigenin-7-O-glucoside at 100 mM. Veh:Vehicle, * indicates Apo B-100 molecular weight and arrow indicates protein fragmentation induced by
oxidation. B: Effect of plant-derived phenolic acids in protein carbonylation in Cu++-incubated LDL. All phenols were tested at three concentrations
(5 mM, 50 mM and 100 mM). LDL and Cu++ incubated LDL were used as control of native and oxidized LDL. The antioxidant capacity of each phenol at
different concentrations is expressed as percentual values, considering that the immunoreactivity of Cu++-incubated LDL is considered 0% of
antioxidant capacity - positive values reveal decreased carbonyl formation and negative values reveal increased protein carbonylation-. LDL
Apoprotein oxidation was also prevented to various extents in oxidation induced with Hemin:H2O2 (C), Ultraviolet radiation (254 nm) (D),
Fe3+:Ascorbate (E), H2O2 (F) and MPO: H2O2 (G) as indicated in the Methods and Materials section. In the case of C-G, phenols were tested at 5 mM. In
these, carbonyl contents are expressed as percentual values, considering that the immunoreactivity of LDL incubated without oxidant (Ctl) as 100%
of carbonyl content. *p,0,05 and ** p,0,01 by ANOVA respect to oxidant-incubated LDL. Data shown are mean6S.D., (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.g001
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Protein antioxidant activity of phenolic acids should be
bioavailable. For this reason we analysed the plasma proteins
from a hypercholesterolemic model (Golden Syrian Hamsters
under hypercholesterolemic diet, showing an increase around
125% in cholesterol levels respect animals under standard chow)
under a diet enriched in vegetable-derived phenols. The polyphe-
nol supplementation did not induce any signs of toxicity nor
changes in alkaline phosphatase, indicating that it was well
tolerated. Despite an effect in LDL cholesterolemia was noted, no
significant differences were evidenced in other values analysed
(Table S1). Nevertheless, the results (Figure 3D) demonstrate that
phenolic-enriched diet significantly diminishes steady state levels of
circulating protein carbonyls. Furthermore, their intake reduces
oxidability of proteins ex vivo under Fe3+-Asc system, both in
hypercholesterolemic hamsters (Figure 3E) and in human plasma
with exogenously added luteolin at 5 mM (Figure 3F). Noteworthy,
compounds with masses compatible with oxidized phospholipids
as PLPC, OGPC and PGPC were detected in the methanolic
extract of hamster plasma (Figure S3, S4, S5). The levels of those
metabolites were diminished in animals under phenolic-enriched
diet (Figure 3G, H and I). Reinforcing the importance of specificity
of oxidative damage measurements, FRAP assay of plasma
demonstrated that polyphenol-enriched diet did not change
antioxidant capacity (Figure 3J), although it changed significantly
profiles of metabolic parameters by hierarchical clustering
(Figure 3K).
Discussion
The present work demonstrates the antioxidant properties of
selected plant-derived phenols (mainly found in olive oil and
grape-derived products) in protein oxidation both in vivo and in
vitro, and the existence of some heterogeneity in the mechanisms.
We offer a novel approach for analysing and screening the
antioxidant properties of natural products over LDL modification,
especially in its protein components. After a screening phase, five
different compounds were selected for further analysis. We have
demonstrated for the first time, the effect of those nutritional
compounds on the accrual of structurally characterized markers of
both protein (GSA, AASA and MDAL) and lipid peroxidation
(POVPC, PGPC) in oxLDL. The pathogenic importance of LDL
protein oxidation is shown by the fact that it was the only factor
that correlated with oxLDL-induced cell death. To extend the
validity to an in vivo setting, we have shown that phenolic intake in
a hypercholesterolemic context diminishes protein carbonyl
content in plasma as well as the concentration of lipid peroxidation
markers.
Figure 2. Cu++-incubated LDL show significant increases in the amounts of mass-spectrometry characterized protein and lipid
oxidation markers, whose formation is inhibited by selected plant-derived phenolic acids. A–C show GC/MS analyses of GSA and AASA
(markers of metal-catalyzed oxidation), and MDAL, originated from lipoxidation. Values shown are % changes of mean6 S.E.M. over values from non-
oxidized LDL (GSA: 5945661 mmol/mol lysine; AASA: 1128620 mmol/mol lysine; and MDAL: 177623 mmol/mol lysine); *p,0,05; ** p,0,01 and ***
p,0,001 respect to Cu++ incubated LDL. D: protein lipoxidative damage shows a quadratic relationship with peroxidizability index (PI)
(r2 = 0,911;p,0,0001; model:[MDAL] = 1,03*[PI]2-151,26*[PI]+5698) E: Pie plot showing distribution of differential (Student’s T test p,0.001) lipid
species between control and Cu++-incubated LDL, after TOF-based lipidome analyses. F: Effect of plant-derived phenolic acids in the accumulation of
PLPC induced by Cu++-incubation. G: Effect of plant-derived phenolic acids in the accumulation of SGPC induced by Cu++-incubation. H: Effect of
plant-derived phenolic acids in the accumulation of POVPC induced by Cu++-incubation. I: Effect of plant-derived phenolic acids in the accumulation
of PGPC induced by Cu++-incubation. Values shown are mean 6 S.E.M. over values from Cu++-incubated LDL, *** p,0,001 (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.g002
Table 2. Effect of Cu++ and phenolic acids in LDL fatty acid composition.
Ctl Cu++ OH-Tyrosol Lut Gall 3,4-DHPEA Pin
16:0 21,1160,59* 24,7860,78 23,3960,84 26,5560,91 24,2560,65 24,7760,8 23,3260,10
16:1n-7 3,0660,28* 3,2760,55 3,0060,66* 3,3360,26 3,2560,87 3,1060,7 3,2660,15
18:0 11,5560,16 11,0860,93 8,9060,30* 11,6360,35 10,0860,41 11,4160,0 9,3660,46*
18:1n-9 22,7760,97** 26,3860,26 24,9160,27 25,3760,06 25,2460,93 25,7460,0 24,6160,69
18:2n-6 28,8460,50** 24,9760,21 30,3960,33** 23,1160,81 28,0260,8** 26,0960,9* 29,7860,13**
20:3n-6 1,5960,47* 0,9860,07 1,3960,85* 0,8860,02 1,1860,14* 1,0160,1 1,2460,22*
20:4n-6 6,0560,96** 3,0860,70 4,6260,19* 2,6760,25 3,7760,14* 3,3260,6 4,2960,65*
ACL 17,7460,9 17,560,7 17,660,2 17,560,1 17,560,8 17,560,7 17,660,1
SFA 34,4161,2* 38,160,3 33,860,0* 40,260,6* 36,160,4 37,960,8 34,660,3*
UFA 65,5962,2* 61,861,7 66,261,0* 59,760,4 63,860,6 62,062,2 65,461,2*
MUFA 26,0760,7* 30,360,5 28,060,2* 28,860,8 28,760,1 29,060,2 28,060,2*
PUFA 39,5260,8** 31,560,2 38,260,1** 30,860,6 35,160,6* 33,060,0 37,460,2*
PUFAn-3 1,6760,02* 0,960,08 1,260,1 0,860,1 1,060,5 1,060,7 1,360,1
PUFAn-6 37,8561,2* 30,560,4 36,960,9* 30,0560,1 34,160,1* 31,960,3 36,160,1*
DBI 124,5863,2** 104,660,6 119,060,6** 103,260,0 111,660,8* 106,660,5 117,360,7**
PI 69,2662,3** 49,160,1 60,660,1** 50,460,2 54,660,9* 51,160,1 59,860,6*
Values: mean6S.E. ACL, average chain length; SFA, saturated fatty acids; UFA, unsaturated fatty acids; PUFA n-6/n-3, polyunsaturated fatty acids n-6 or n-3 series; MUFA,
monounsaturated fatty acids; DBI, double bond index; PI, peroxidizability index,
*p,0,05 and ** p,0,01 respect to values in Cu++ incubated LDL by ANOVA post-hoc analyses (n = 4 for each data point).
doi:10.1371/journal.pone.0043308.t002
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In order to establish whether structural features determine the
effect on the resistance of LDL to Cu++-induced oxidation, the
chemical structures of the phenolic compounds should be
considered (Figure S1). Important differences in the protection
of the apoprotein oxidation were observed in this study, similar to
those observed by other authors using the lag time of LDL as
marker oxidation [40,41]. The differences between those phenols
are attributable to their chemical structure, e.g. OH-tyrosol
possesses a 3,4-dihydroxy structure linked to an aromatic ring that
confers the moiety with a higher proton dislocation, facilitating a
higher scavenging activity than observed with tyrosol, which only
has a hydroxyl group linked to an aromatic ring (Figure S1). The
protective effect of the OH-tyrosol structure has biological
relevance as OH-tyrosol and tyrosol are the more simple phenols
detected in plasma and LDL after the ingestion of virgin olive oil
and red wine [42,43]. It should be noted that OH-tyrosol, with the
highest potential for inhibition of MDAL, has been previously
described as a potent inducer of cellular antioxidant responses,
both in oxLDL-induced and in tert-BOOH-induced cell stress
[36,44].
The antioxidant capacity shown by oleuropein and its
secoiridoid derivatives was quite different. The aglicon derivative
of oleuropein (3,4-DHPEA-EDA) and the ligstroside derivative (p-
HPEA-EDA) showed a positive result as antioxidants, mainly at
the maximum concentration tested. These compounds exhibit a
high selectivity for lipid-related changes since they mainly
prevented Cu++ induced changes in lipidome and MDAL in
LDL. Although no previous results were available on lipid or
protein antioxidant properties, 3,4-DHPEA-EDA is a compound
of special interest because of its presence as one of the major
phenolic antioxidant compounds in virgin olive oil. Moreover, it is
an important source of OH-tyrosol in plasma. In contrast with
these data, a similar phenolic structure, the 3,4-DHPEA-AC
showed no significant antioxidant activity in this system. This may
be attributed to the potential proton dislocation due to double
bonds in the elenolic structure in 3,4-DHPEA-EDA. Reinforcing
the importance of conjugation, oleuropein, or glucose-conjugated
elenolic acid, showed the more remarkable prooxidant activity of
all phenols included in the study in agreement with its previous
reported pro-oxidant activities [45,46]. Most interestingly, as
oleuropein is considered a proapoptotic agent with potential use as
an anti-tumoral agent [47,48], it may be suggested that those
protein prooxidant properties could be involved in the beneficial
effects of oleuropein.
Flavonoids such as rutin, flavones (apigenin and luteolin), and
their glucosides (apigenin-7-O-glucoside and luteolin-7-O-gluco-
side) can scavenge reactive oxygen radicals, by donating a
hydrogen atom or electron [49,50]. Their radical scavenging
activity seems to be substantially dependent on three structural
groups: (i) the orto-dihydroxyl structure (catechol structure) in the B
ring, which is the obvious radical target site, (ii) the 2,3 double
bond in conjunction with 4-oxo function, which is responsible for
electron delocalization, and (iii) the additional presence of both the
3- and the 5-OH groups for maximal radical scavenging potential
and the strongest radical absorption. Our data suggest the
importance of the ortho-dihydroxyl structure in the prevention of
protein modification, as luteolin and rutin -both containing this
structure- act as more effective antioxidants than apigenin, a very
similar molecule. Comparing the antioxidant activity in the
copper-induced LDL oxidation of the luteolin and luteolin-7-O-
glucoside, the antioxidant capacity of both structures was similar.
Despite the described preventive effects of those flavonoids in the
diminution of the lag-phase of LDL induced by Cu++ and other
oxidants [51,52] no data were available on their role as inhibitors
of protein oxidation markers. In fact, luteolin can be classified as
an agent with more potential for preventing direct oxidation (i.e.
GSA and AASA accumulation) than for preventing lipid
peroxidation, as it shows a lower power for protecting against
Cu++-induced lipidome changes in LDL, in agreement with
previous data showing a modest inhibition in the formation of
thiobarbituric acid-reactive substances driven by Cu++ [53]. In
contrast with this relative low in vitro potential, it shows a high
efficiency in both cell systems as it is able to completely block tert-
BOOH-induced changes in cell viability and it shows a high
potential against oxLDL-induced cell death, in agreement with the
reported inhibitory effect of luteolin in oxidized LDL-induced
endothelial monocyte adhesion and/or oxidised LDL uptake [53].
Other major phenols quantified in virgin olive oils and grape-
derived products are lignans, with a 2,3-dibenzylbutane skeleton,
whose concentration is related to the olive cultivar of origin [54].
Although they are important as sources of lignans enterodiol and
enterolactone by colonic flora metabolism, our data reveal that
acetoxypinoresinol and pinoresinol possess antioxidant activity, in
agreement with previous reports, where it was shown that some
vegetable extracts, rich in pinoresinol, were able to inhibit LDL
oxidation [55,56]. Their antioxidant activity could be more closely
related to their chelating properties than scavenging activity, as
they only exhibit a hydroxyl group linked to an aromatic ring.
Figure 3. Plant-derived phenolic acids inhibit both the effects of oxidative stress in endothelial and HepG2 cell culture and protein
oxidation in diet-induced hypercholesterolemia in vivo. A: Effect of plant-derived phenolic acids in cell death in HMEC (endothelial cell line)
induced by Cu++-incubated LDL; ** p,0,01 and *** p,0,001 respect to cell death induced by Cu++ incubated LDL (n = 6 for each data point). Values
shown are mean6 S.E.M. over values from samples treated with control LDL B: Effect of plant-derived phenolic acids in HepG2 capacity to withstand
t-BOOH induced cell death; *** p,0,001 respect to cell death induced by t-BOOH (n = 6 for each data point). Values shown are % changes of mean6
S.E. over values from control samples. C: Endothelial cell death induced by Cu++-incubated LDL is strongly correlated with GSA content (r =20.734;
p,0,016 by the Pearson correlation test). To validate this in vivo, proteins from hypercholesterolemic hamsters were analyzed for carbonyl content
(D). Both plasma from hypercholesterolemic hamsters with a dietary supplement of phenolic acid-enriched vegetal extract (E) and pooled human
plasma (F) were oxidized with Fe3+-Asc as indicated in the Methods and Material section. Aliquots were taken at indicated time points and processed
for determination of carbonyl content. G: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound compatible with PLPC
in plasma from hypercholesterolemic hamsters. H: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound compatible
with OGPC in plasma from hypercholesterolemic hamsters. I: Effect of phenolic acids-enriched diet intake in the steady state levels of a compound
compatible with PGPC in plasma from hypercholesterolemic hamsters. J: Effect of phenolic acids-enriched diet intake in FRAP activity of plasma. K:
Heat-map showing that phenolic acids-enriched diet induces a significant hierarchical clustering of measured parameters, including both oxidative
damage and metabolic (cholesterol, HDL and LDL-cholesterol, triacilglyceride and alkaline phosphatase activities), revealing an important biological
effect. The carbonyl content is expressed as a percentual value, considering that the immunoreactivity of plasma from hypercholesterolemic hamsters
individuals (Controls in D) or protein incubated without oxidant (Ctl) (in E) as 100% of carbonyl content. ** p,0,01 by Student’s T test respect to
untreated animals (E,G,H,I,J) or oxidant-incubated human plasma (F). Data shown are mean6S.E.M., (n = 4 for each data point). For clustering
analyses, values of samples were log transformed and hierarchical clustering was performed using Pearson correlation coefficient as distance measure
and the Ward’s clustering algorithm. Colors in K express intensity/abundance with red colors showing high levels and blue colors lower levels.
doi:10.1371/journal.pone.0043308.g003
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Globally, acetoxypinoresinol and pinoresinol exhibit similar
potencies in the inhibition of direct protein oxidation and lipid
peroxidative damage, as well as in the prevention of lipidome
changes induced by Cu++.
With regard to the phenolic acid group (ferulic, cumaric, caffeic
and gallic acids) (Figure S1), all the phenols showed antioxidant
capacity at 50 and 100 mM. Ferulic and p-cumaric acids showed a
slight prooxidant activity at 5 mM, that may be attributed to H2O2
in vitro production from phenolic compounds [57,58]. According to
their mechanism of action, the phenolic acids may be classified as
free radical terminators interfering with lipid oxidation by rapid
donation of a hydrogen atom to peroxy radicals. Their antioxidant
activity is related to the molecule containing at least two
neighbouring phenolic hydroxyl groups; three such groups are
even more desirable facilitating the interference. Results of the
present study showed that the caffeic (with two neighbouring
phenolic hydroxyl groups) and gallic acids (three hydroxyl groups)
shown to have the highest antioxidant capacity. Previous results
have demonstrated the antioxidant capacity of gallic and caffeic
acids on lipid peroxidation [59–61], but only one reported the
effect of gallic acids on protein modification, and that was related
to nitrosative stress [62]. Concerning their cellular effects, gallic
and caffeic acid differed in their effects: while gallic acid was
unable to prevent oxLDL-induced or tBOOH-induced loss of
viability, caffeic acid inhibited the toxic effects of oxLDL (data not
shown). This agrees with the known effect of gallic acid as a
proapoptotic agent [63–65] and the reported protective effect of
caffeic acid in endothelial cell survival after oxLDL treatment [66].
All the phenols studied showed antioxidant capacity in the LDL
model, the OH-tyrosol being the more effective. In general, all the
phenols showed higher antioxidant activity than a-tocopherol,
which could be attributed to the hydrophilic nature of the phenolic
structures. In the biphasic microenvironment constituting core
lipids and water phase, such as biomembranes and plasma
lipoproteins, the location of phenols should be taken into account
for understanding their antioxidant activity. Vitamin E (a-
tocopherol) seems to be located within the membrane lipids or
lipoprotein particles because of its high lipophilicity. However, it is
demonstrated that flavonoid aglycones interact in the polar surface
region of the phospholipids bilayers in membranes [67], offering a
higher protection. This is specially relevant assuming that the
antioxidant profile is completely dependent on the system. As
shown by experiments with BSA and human plasma, phenolic
interaction in protein oxidation is a very complex phenomenon,
which depends on not only of the system used for oxidation, but
also on the protein, the presence of lipids and the several
mechanisms between protein-phenol and free radical source.
In summary, these data show novel antioxidant properties of
plant-derived phenolic acid compounds in LDL oxidation and
demonstrates phenolic activity in protein oxidation in vivo. It is also
demonstrated that in vitro antioxidant measurements could only
partially predict biologic responses to oxidized LDL, thus
reinforcing the importance of a multidisciplinary approach for
the description of oxidative phenomena in atherosclerosis patho-
genesis and its dietary modulation.
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